Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 7, Pages 934
Publisher
MDPI AG
Online
2019-07-03
DOI
10.3390/cancers11070934
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells
- (2019) Ilana Chefetz et al. Cell Reports
- An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
- (2019) Oded Kopper et al. NATURE MEDICINE
- A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer
- (2019) Nkechiyere Nwani et al. Cancers
- Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients
- (2019) Beáta Soltész et al. JOURNAL OF BIOTECHNOLOGY
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses
- (2018) Daniela Matei et al. CLINICAL CANCER RESEARCH
- Dual Src and MEK inhibition decreases ovarian cancer growth and targets tumor initiating stem-like cells
- (2018) Fiona Simpkins et al. CLINICAL CANCER RESEARCH
- Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients
- (2018) Kui Deng et al. GYNECOLOGIC ONCOLOGY
- Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma
- (2018) Madhuchhanda Roy et al. HUMAN PATHOLOGY
- Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells
- (2018) Peng-Chan Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity
- (2018) Shyh-Ming Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic Targeting of Adipocytes Inhibits High-Grade Serous Ovarian Cancer Cell Migration and Invasion
- (2018) Jessica Tang et al. MOLECULAR CANCER RESEARCH
- Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer
- (2018) Bayley A. Jones et al. MOLECULAR CANCER THERAPEUTICS
- Adaptive Resistance to Chemotherapy, A Multi–FAK-torial Linkage
- (2018) Kristin N. Taylor et al. MOLECULAR CANCER THERAPEUTICS
- Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis
- (2018) Stephan Marquardt et al. SEMINARS IN CANCER BIOLOGY
- Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers
- (2018) Cindy M. Yamamoto et al. Journal of Ovarian Research
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy
- (2018) Brandt C. Huddle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mesothelial cells facilitate cancer stem‑like properties in spheroids of ovarian cancer cells
- (2018) Akemi Shishido et al. ONCOLOGY REPORTS
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- CD133 as a regulator of cancer metastasis through the cancer stem cells
- (2018) Geou-Yarh Liou INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- PARP inhibition induces enrichment of DNA repair proficient CD133 and CD117 positive ovarian cancer stem cells
- (2018) Chiara Bellio et al. MOLECULAR CANCER RESEARCH
- An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
- (2018) Takeshi Motohara et al. ONCOGENE
- Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth
- (2018) Karen McLean et al. ONCOGENE
- Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression
- (2018) Subramanyam Dasari et al. Cancers
- Ovarian cancer stem cells: What progress have we made?
- (2018) Linah F. Al-Alem et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor–Based Immunotherapy and Chemotherapy
- (2017) Rüdiger Klapdor et al. HUMAN GENE THERAPY
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
- (2017) Masaru Katoh INTERNATIONAL JOURNAL OF ONCOLOGY
- CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma
- (2017) Alena Bartakova et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Epigenetics in cancer stem cells
- (2017) Tan Boon Toh et al. Molecular Cancer
- The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
- (2017) Xiaoduan Li et al. Molecular Cancer
- Ovarian cancer stem cells: still an elusive entity?
- (2017) Michela Lupia et al. Molecular Cancer
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
- (2017) Kiyoko Nakamura et al. ONCOLOGY REPORTS
- Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis
- (2017) Bikang Yang et al. OncoTargets and Therapy
- BET Proteins as Targets for Anticancer Treatment
- (2017) Anastasios Stathis et al. Cancer Discovery
- Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer
- (2017) Ali R. Özeş et al. Scientific Reports
- Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment
- (2017) Jeffrey Koury et al. Stem Cells International
- The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
- (2017) Thomas Worzfeld et al. Frontiers in Oncology
- The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer
- (2017) Curtis Balch et al. Cancer Biomarkers
- Tumor microenvironment: The culprit for ovarian cancer metastasis?
- (2016) Zhongyue Luo et al. CANCER LETTERS
- BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
- (2016) Yuhki Yokoyama et al. CANCER RESEARCH
- Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer
- (2016) Soochi Kim et al. CANCER SCIENCE
- Exosomes
- (2016) Michael E. Davis CIRCULATION RESEARCH
- RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
- (2016) Yajing Liu et al. CLINICAL CANCER RESEARCH
- The epigenetics of tumour initiation: cancer stem cells and their chromatin
- (2016) Alexandra Avgustinova et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks inex vivoculture
- (2016) Fanny Grillet et al. GUT
- Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752
- (2016) XiuXiu Chen et al. GYNECOLOGIC ONCOLOGY
- Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy
- (2016) Allison C. Sharrow et al. GYNECOLOGIC ONCOLOGY
- Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide
- (2016) Naveena Singh et al. GYNECOLOGIC ONCOLOGY
- Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines
- (2016) Radosſaw Januchowski et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- SiRNA and epigenetic aberrations in ovarian cancer
- (2016) HamidReza Mirzaei et al. Journal of Cancer Research and Therapeutics
- Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
- (2016) Koji Nakamura et al. MOLECULAR CANCER RESEARCH
- Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel
- (2016) Christina Blassl et al. Molecular Oncology
- Targeting the cancer epigenome for therapy
- (2016) Peter A. Jones et al. NATURE REVIEWS GENETICS
- NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
- (2016) A R Özeş et al. ONCOGENE
- Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
- (2016) A E Witt et al. ONCOGENE
- Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer
- (2016) Yu-mei Ma et al. OncoTargets and Therapy
- Effects of anti-CD44 monoclonal antibody IM7 carried with chitosan polylactic acid-coated nano-particles on the treatment of ovarian cancer
- (2016) Yizhuo Yang et al. Oncology Letters
- Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube
- (2016) M. A. Eckert et al. Cancer Discovery
- Cisplatin induces stemness in ovarian cancer
- (2016) Andrew Wiechert et al. Oncotarget
- CD133, Selectively Targeting the Root of Cancer
- (2016) Jörg Schmohl et al. Toxins
- DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis
- (2016) Eunsohl Lee et al. NEOPLASIA
- Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
- (2015) Ernst Lengyel et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
- (2015) Tsz-Lun Yeung et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Exosomes: Emerging biomarkers and targets for ovarian cancer
- (2015) Maggie K.S. Tang et al. CANCER LETTERS
- Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors
- (2015) Mauricio Rodriguez-Torres et al. CLINICAL & EXPERIMENTAL METASTASIS
- A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
- (2015) E. G. Chiorean et al. CLINICAL CANCER RESEARCH
- Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus
- (2015) Chin-Hsiao Tseng DIABETES-METABOLISM RESEARCH AND REVIEWS
- A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia
- (2015) Ivan Diaz-Padilla et al. GYNECOLOGIC ONCOLOGY
- A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
- (2015) Suzanne F. Jones et al. INVESTIGATIONAL NEW DRUGS
- Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
- (2015) Dmitri Pchejetski et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78
- (2015) L. Mo et al. MOLECULAR CANCER THERAPEUTICS
- CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
- (2015) D. Burgos-Ojeda et al. MOLECULAR CANCER THERAPEUTICS
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
- (2015) Devon A. Lawson et al. NATURE
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
- (2015) Phuong N. Le et al. PHARMACOLOGY & THERAPEUTICS
- DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis
- (2015) Rajneesh Pathania et al. Nature Communications
- Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44+CD117+ ovarian cancer stem cells
- (2015) Rongrong Zhang et al. Stem Cell Research & Therapy
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Activation of Multiple ERBB Family Receptors Mediates Glioblastoma Cancer Stem-like Cell Resistance to EGFR-Targeted Inhibition
- (2015) Paul A. Clark et al. NEOPLASIA
- Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
- (2014) Sunila Pradeep et al. CANCER CELL
- Epigenetic Targeting of Ovarian Cancer Stem Cells
- (2014) Yinu Wang et al. CANCER RESEARCH
- The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer
- (2014) F. Fang et al. CLINICAL CANCER RESEARCH
- Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer
- (2014) Nina R. Shah et al. GYNECOLOGIC ONCOLOGY
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
- (2014) S Condello et al. ONCOGENE
- ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
- (2014) Erhong Meng et al. PLoS One
- An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma
- (2014) Maria Giuseppina Baratta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway
- (2014) Te Liu et al. TUMOR BIOLOGY
- The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment
- (2014) Jun Ye et al. TUMOR BIOLOGY
- Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition
- (2014) Jessica E. Bolden et al. Cell Reports
- Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer
- (2014) Tae Hun Kim et al. Biomed Research International
- Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
- (2013) Christine L. Chaffer et al. CELL
- Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug
- (2013) V. Shah et al. CLINICAL CANCER RESEARCH
- Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
- (2013) Amy P.N. Skubitz et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer stem cells: Are they real and why are they important?
- (2013) Monjri M. Shah et al. GYNECOLOGIC ONCOLOGY
- CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis
- (2013) Jing Zhang et al. HUMAN PATHOLOGY
- CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
- (2013) Rosa Nadal et al. INTERNATIONAL JOURNAL OF CANCER
- Effects and Mechanisms of Anti-CD44 Monoclonal Antibody A3D8 on Proliferation and Apoptosis of Sphere-Forming Cells With Stemness From Human Ovarian Cancer
- (2013) Yong-Rui Du et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Stem-Cell Profile of Ovarian Surface Epithelium is Reproduced in the Oviductal Fimbriae, with Increased Stem-Cell Marker Density in Distal Parts of the Fimbriae
- (2013) Nelly Auersperg INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Extracellular vesicles: Exosomes, microvesicles, and friends
- (2013) Graça Raposo et al. JOURNAL OF CELL BIOLOGY
- Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
- (2013) Khalid Abubaker et al. Molecular Cancer
- Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
- (2013) Andrea Flesken-Nikitin et al. NATURE
- Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer
- (2013) T Xiang et al. ONCOGENE
- Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
- (2013) Naoko Takebe et al. PHARMACOLOGY & THERAPEUTICS
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
- (2012) Appalaraju Jaggupilli et al. Clinical & Developmental Immunology
- Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression
- (2012) Kristy K. Ward et al. CLINICAL & EXPERIMENTAL METASTASIS
- Metformin targets ovarian cancer stem cells in vitro and in vivo
- (2012) Jessica J. Shank et al. GYNECOLOGIC ONCOLOGY
- Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors
- (2012) Grazia Carbotti et al. INTERNATIONAL JOURNAL OF CANCER
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling
- (2012) W K Chau et al. ONCOGENE
- Metformin inhibits the development and metastasis of ovarian cancer
- (2012) BUCHU WU et al. ONCOLOGY REPORTS
- Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
- (2012) Ardian Latifi et al. PLoS One
- Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
- (2012) S. M. McAuliffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Colorectal Cancer Stem Cells
- (2012) Aristides G. Vaiopoulos et al. STEM CELLS
- Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
- (2012) Ramandeep Rattan et al. Journal of Oncology
- Optical Quantification of Cellular Mass, Volume, and Density of Circulating Tumor Cells Identified in an Ovarian Cancer Patient
- (2012) Kevin G. Phillips et al. Frontiers in Oncology
- ALDH1A1 Is a Novel EZH2 Target Gene in Epithelial Ovarian Cancer Identified by Genome-Wide Approaches
- (2011) H. Li et al. Cancer Prevention Research
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
- (2011) Paola Marcato et al. CELL CYCLE
- Distinct Types of Tumor-Initiating Cells Form Human Colon Cancer Tumors and Metastases
- (2011) Sebastian M. Dieter et al. Cell Stem Cell
- Cancer Stem Cells and Chemosensitivity
- (2011) M. Maugeri-Sacca et al. CLINICAL CANCER RESEARCH
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
- (2011) Lijing Luo et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer
- (2011) Andres Poveda et al. GYNECOLOGIC ONCOLOGY
- The functional role of long non-coding RNA in human carcinomas
- (2011) Ewan A Gibb et al. Molecular Cancer
- Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
- (2011) S. Rizzo et al. MOLECULAR CANCER THERAPEUTICS
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44
- (2010) Anoma Somasunderam et al. BIOCHEMISTRY
- Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer
- (2010) Siqing Fu et al. CANCER
- A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer
- (2010) Fang Fang et al. CANCER
- Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line
- (2010) M. F. Shi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion
- (2010) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
- (2010) Shan Deng et al. PLoS One
- Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
- (2009) Jianghong Li et al. BMC CANCER
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides
- (2009) M. G. Slomiany et al. CLINICAL CANCER RESEARCH
- Minireview: Epigenetic Changes in Ovarian Cancer
- (2009) Curt Balch et al. ENDOCRINOLOGY
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
- (2009) Michael D. Curley et al. STEM CELLS
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer
- (2008) Tina Fan et al. GYNECOLOGIC ONCOLOGY
- Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
- (2008) Russell J. Schilder et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started